NFE2L2 and inflammatory bowel disease: However, one study has examined the potential of NRF2 activation to ameliorate photodermatoses; Kalra et al. explored the impact of TBE-31 (NRF2 activator) on photosensitization caused by azathioprine, an immunosuppressive drug widely used in inflammatory bowel disease and organ transplantations.